Attached files
file | filename |
---|---|
10-K - ZIOPHARM ONCOLOGY INC | v177246_10k.htm |
EX-23.1 - ZIOPHARM ONCOLOGY INC | v177246_ex23-1.htm |
EX-33.2 - ZIOPHARM ONCOLOGY INC | v177246_ex32-2.htm |
EX-31.1 - ZIOPHARM ONCOLOGY INC | v177246_ex31-1.htm |
EX-31.2 - ZIOPHARM ONCOLOGY INC | v177246_ex31-2.htm |
EX-10.16 - ZIOPHARM ONCOLOGY INC | v177246_ex10-16.htm |
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Annual Report of ZIOPHARM Oncology, Inc. (the “Company”) on
Form 10-K for the year ended December 31, 2009, as filed with the Securities and
Exchange Commission on the date hereof (the “Report”), I, Jonathan Lewis,
Principal Executive Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:
(1)
|
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and
|
|
(2)
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the
Company.
|
/s/
Jonathan Lewis
|
Jonathan
Lewis, Chief Executive Officer
|
(Principal
Executive Officer)
|
March
17, 2010
|